Effects of isradipine, a dihydropyridine-class calcium channel antagonist, on D-methamphetamine-induced cognitive and physiological changes in humans

被引:55
作者
Johnson, BA [1 ]
Ait-Daoud, N [1 ]
Wells, LT [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Psychiat, San Antonio, TX 78284 USA
关键词
methamphetamine; isradipine; hypertension; calcium channel blockers; attention; cognition; humans;
D O I
10.1016/S0893-133X(99)00116-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
D-methamphetamine is abused for its euphoric effects and stimulatory action on cognitive function. Its abuse can, however, be associated with massive hypertension resulting in strokes, ruptured aneurysms, or myocardial infarction. We examined the utility of isradipine, a dihydropyridine-class calcium channel antagonist, in treating d-methamphetamine induced hypertension and evaluated its effects on cognitive function, both of which are mediated by dopaminergic mechanisms. D-methamphetamine dose-dependently increased all vital signs (systolic, diastolic, and mean arterial pressure, and pulse rate) parameters. Isradipine significantly reduced d-methamphetamine-induced increases in diastolic and mean arterial pressure; however, this potentially beneficial therapeutic effect was offset by a significant reflex rise in pulse rate, D-methamphetamine also improved attention, accuracy of reasoning ability, and performance on computerized cognitive function tasks. D-methamphetamine's cognitive improving effects were not altered significantly by isradipine. Isradipine increased the false responding rate but was without significant effect on any other attentional task, or on reasoning ability, or performance, Isradipine does not appear to enhance cognitive function in healthy humans. (C) 2000 American College of Neuropsychopharmacology.
引用
收藏
页码:504 / 512
页数:9
相关论文
共 54 条
[21]   Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: Oxidative consequences? [J].
Hanson, GR ;
Gibb, JW ;
Metzger, RR ;
Kokoshka, JM ;
Fleckenstein, AE .
NEUROCHEMISTRY OF DRUGS OF ABUSE: COCAINE, IBOGAINE, AND SUBSTITUTED AMPHETAMINES, 1998, 844 :103-107
[22]   BEHAVIORAL PHARMACOLOGY OF CENTRAL-NERVOUS-SYSTEM STIMULANTS [J].
HARVEY, JA .
NEUROPHARMACOLOGY, 1987, 26 (7B) :887-892
[23]   Pharmacotherapy in Alzheimer's dementia: Treatment of cognitive symptoms - Results of new studies [J].
Heidrich, A ;
Rosler, M ;
Riederer, P .
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 1997, 65 (03) :108-121
[24]  
JERZY V, 1997, PHARM BIOCH BEHAV, V56, P577
[25]   Isradipine prevents global and regional cocaine-induced changes in brain blood flow: A preliminary study [J].
Johnson, B ;
Barron, B ;
Fang, B ;
Lamki, L ;
Wagner, L ;
Wells, L ;
Kenny, P ;
Overton, D ;
Dhother, S ;
Abramson, D ;
Chen, R ;
Kramer, L .
PSYCHOPHARMACOLOGY, 1998, 136 (04) :335-341
[26]  
Johnson B, 1999, HUM PSYCHOPHARM CLIN, V14, P37, DOI 10.1002/(SICI)1099-1077(199901)14:1<37::AID-HUP62>3.0.CO
[27]  
2-T
[28]  
JOHNSON B, 1997, 59 ANN COLL PROBL DR
[29]  
Johnson BA, 1996, BEHAV PHARMACOL, V7, P216
[30]  
JOHNSON BA, 1998, COLL INT NEUR GLASG